Stargardt Disease study: AAVB-039
Official title A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
ClinicalTrials.gov ID: NCT07161544
What this study is testing
What is AAVB-039?
This is an investigational biological medicine being studied as a potential treatment for Stargardt disease.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether a new gene therapy is safe. It also looks at how well it works.
- Who it's for
- You may be able to join if you have Stargardt disease caused by a specific gene change.
- What's involved
- You would get one injection of the medicine under your retina. The team will check your eyes to see how you do.
- Time commitment
- The study involves visits to check your safety and how well the treatment works.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 55
You may be able to join if
- Molecular diagnosis of Stargardt disease due to ABCA4 mutation
- Willingness to adhere to protocol per informed consent
You likely can't join if
- Unwillingness to meet the requirements of the study
- Participation in a clinical study with another Investigation Medicinal Product
- Previous participation in another gene or cell therapy trial
- Any condition that would preclude subretinal surgery
- Complicating ocular and/or systemic diseases
The study team makes the final eligibility decision.
Where it is enrolling
- Phoenix, Arizona, United States
- Los Angeles, California, United States
- Jacksonville, Florida, United States
- Rochester, Minnesota, United States
- Bellaire, Texas, United States
- Dallas, Texas, United States
- Salt Lake City, Utah, United States
- Oslo, Kirkeveien 166, Norway
- London, England, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Phoenix, Arizona, United States; Los Angeles, California, United States; Jacksonville, Florida, United States; Rochester, Minnesota, United States; Bellaire, Texas, United States; Dallas, Texas, United States and 3 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.